Bernard Kaptein
Research Subjects
Bernard Kaptein has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Wells
Global Process R&D, AstraZeneca, Leicestershire, U.K.
3 shared publications Bill Hinkley
GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A.
3 shared publications- David Hughes
Cidara Therapeutics, Inc., 6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121, United States
3 shared publications Ian Andrews
GlaxoSmithKline, Stevenage, Hertfordshire, U.K.
3 shared publications- Iaroslav Baglai
AMOLF Science Park 104 1098 XG Amsterdam The Netherlands
3 shared publications - John Hayler
Chemical Development, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 20 February 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (26) , 3838-3841
Rapid deracemization through solvent cycling: proof-of-concept using a racemizable conglomerate clopidogrel precursor
Using a Soxhlet-apparatus, we demonstrate that a conglomerate-forming clopidogrel precursor undergoing solution phase racemization can be deracemized through cyclic solvent removal and re-addition.
- 20 February 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (26) , 3838-3841
Open AccessRapid deracemization through solvent cycling: proof-of-concept using a racemizable conglomerate clopidogrel precursor
Using a Soxhlet-apparatus, we demonstrate that a conglomerate-forming clopidogrel precursor undergoing solution phase racemization can be deracemized through cyclic solvent removal and re-addition.
- 26 November 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (10) , 5279-5282
Combining Incompatible Processes for Deracemization of a Praziquantel Derivative under Flow Conditions
An efficient deracemization method for conversion of the racemate to the desirable (R)‐enantiomer of Praziquantel has been developed by coupling incompatible racemization and crystallization processes. By a library approach, a derivative that crystallizes as a conglomerate has been identified. Racemization occurs via reversible hydrogenation over a palladium on carbon (Pd/C) packed column at 130 °C, whereas deracemization is achieved by alternating crystal growth/dissolution steps with temperature cycling between 5–15 °C. These incompatible processes are combined by means of a flow system resulting in complete deracemization of the solid phase to the desired (R)‐enantiomer (98 % ee). Such an unprecedented deracemization by a decoupled crystallization/racemization approach can readily be turned into a practical process and opens new opportunities for the development of essential enantiomerically pure building blocks that require harsh methods for racemization.
- 26 November 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (10) , 5279-5282
Combining Incompatible Processes for Deracemization of a Praziquantel Derivative under Flow Conditions
An efficient deracemization method for conversion of the racemate to the desirable (R)‐enantiomer of Praziquantel has been developed by coupling incompatible racemization and crystallization processes. By a library approach, a derivative that crystallizes as a conglomerate has been identified. Racemization occurs via reversible hydrogenation over a palladium on carbon (Pd/C) packed column at 130 °C, whereas deracemization is achieved by alternating crystal growth/dissolution steps with temperature cycling between 5–15 °C. These incompatible processes are combined by means of a flow system resulting in complete deracemization of the solid phase to the desired (R)‐enantiomer (98 % ee). Such an unprecedented deracemization by a decoupled crystallization/racemization approach can readily be turned into a practical process and opens new opportunities for the development of essential enantiomerically pure building blocks that require harsh methods for racemization.
- 26 November 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (10) , 5339-5342
Combining Incompatible Processes for Deracemization of a Praziquantel Derivative under Flow Conditions
An efficient deracemization method for conversion of the racemate to the desirable (R)‐enantiomer of Praziquantel has been developed by coupling incompatible racemization and crystallization processes. By a library approach, a derivative that crystallizes as a conglomerate has been identified. Racemization occurs via reversible hydrogenation over a palladium on carbon (Pd/C) packed column at 130 °C, whereas deracemization is achieved by alternating crystal growth/dissolution steps with temperature cycling between 5–15 °C. These incompatible processes are combined by means of a flow system resulting in complete deracemization of the solid phase to the desired (R)‐enantiomer (98 % ee). Such an unprecedented deracemization by a decoupled crystallization/racemization approach can readily be turned into a practical process and opens new opportunities for the development of essential enantiomerically pure building blocks that require harsh methods for racemization.
- 26 November 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (10) , 5339-5342
Combining Incompatible Processes for Deracemization of a Praziquantel Derivative under Flow Conditions
An efficient deracemization method for conversion of the racemate to the desirable (R)‐enantiomer of Praziquantel has been developed by coupling incompatible racemization and crystallization processes. By a library approach, a derivative that crystallizes as a conglomerate has been identified. Racemization occurs via reversible hydrogenation over a palladium on carbon (Pd/C) packed column at 130 °C, whereas deracemization is achieved by alternating crystal growth/dissolution steps with temperature cycling between 5–15 °C. These incompatible processes are combined by means of a flow system resulting in complete deracemization of the solid phase to the desired (R)‐enantiomer (98 % ee). Such an unprecedented deracemization by a decoupled crystallization/racemization approach can readily be turned into a practical process and opens new opportunities for the development of essential enantiomerically pure building blocks that require harsh methods for racemization.
- 14 December 2010
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 15 (1) , 22-30
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 14 December 2010
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 15 (1) , 22-30
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 11 December 2009
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 14 (1) , 19-29
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 11 December 2009
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 14 (1) , 19-29
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 15 May 2009
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 13 (3) , 397-408
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 15 May 2009
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 13 (3) , 397-408
Green Chemistry Articles of Interest to the Pharmaceutical Industry
- 1 September 2005
- Published by Elsevier in Tetrahedron Letters
- Vol. 46 (37) , 6369-6371
Amino acid bromides: their utilization for difficult couplings in solid-phase peptide synthesis
- 1 September 2005
- Published by Elsevier in Tetrahedron Letters
- Vol. 46 (37) , 6369-6371
Amino acid bromides: their utilization for difficult couplings in solid-phase peptide synthesis
- 19 May 1998
- Published by Wiley in ChemInform
- Vol. 29 (20)
ChemInform Abstract: New Resolving Bases for Ibuprofen and Mandelic Acid: Qualification by Binary Phase Diagrams.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
- 19 May 1998
- Published by Wiley in ChemInform
- Vol. 29 (20)
ChemInform Abstract: New Resolving Bases for Ibuprofen and Mandelic Acid: Qualification by Binary Phase Diagrams.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.